The Global Cisplatin API Market was valued at USD 175.3 Million in 2024 and is projected to reach USD 245.8 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period (2024–2030). This sustained growth is primarily driven by the rising global incidence of various cancers, expanding applications of cisplatin in combination therapies, and the increasing demand for high-purity Active Pharmaceutical Ingredients (APIs) from generic drug manufacturers.

As the oncology pharmaceutical landscape evolves with more targeted treatments, the foundational role of chemotherapy agents like cisplatin remains critical. The companies producing the cisplatin API are at the heart of this ecosystem, ensuring a reliable supply of this essential chemotherapeutic agent. In this analysis, we profile the Top 10 Companies in the Cisplatin API Industry—a mix of specialty chemical manufacturers, large pharmaceutical firms, and dedicated API suppliers shaping the future of cancer care.

Download FREE Sample Report:
Cisplatin API Market – View in Detailed Research Report

---

🔟 1. Qilu Pharmaceutical Co., Ltd.

Headquarters: Jinan, Shandong, China
Key Offering: Cisplatin API (Purity 98%, Purity 99%)

Qilu Pharmaceutical is one of China’s leading pharmaceutical companies and a major global supplier of cisplatin API. With extensive manufacturing capabilities and rigorous quality control systems, Qilu supplies bulk cisplatin to both domestic and international markets, supporting the production of injectable chemotherapy drugs.

Strategic Initiatives:

• Significant investment in API manufacturing capacity expansion

• Strong focus on regulatory compliance across multiple markets (CFDA, FDA, EMA)

• Vertical integration from raw materials to finished dosage forms

---

9️⃣ 2. Cipla Limited

Headquarters: Mumbai, Maharashtra, India
Key Offering: Cisplatin API and Finished Formulations

Cipla is a global pharmaceutical giant with a strong presence in oncology. The company manufactures cisplatin API for its own extensive portfolio of anti-cancer drugs and also supplies the API to other manufacturers. Cipla’s expertise spans the entire value chain, from API synthesis to finished sterile injectables.

Strategic Initiatives:

• Leadership in affordable cancer care across emerging markets

• Continuous process optimization for cost-effective API production

• Expanding global regulatory filings for cisplatin API

---

8️⃣ 3. Heraeus Deutschland GmbH & Co. KG

Headquarters: Hanau, Germany
Key Offering: High-Purity Platinum Compounds and Cisplatin API

Heraeus, a German technology group with a long history in precious metals, is a key player in the cisplatin API market. Leveraging its expertise in platinum chemistry, Heraeus produces high-purity cisplatin API for the pharmaceutical industry, ensuring stringent quality standards required for oncology applications.

Strategic Initiatives:

• Proprietary platinum refining and synthesis technologies

• Focus on high-value specialty metals for pharmaceuticals

• Strategic partnerships with major pharmaceutical companies

---

7️⃣ 4. Johnson Matthey PLC

Headquarters: London, United Kingdom
Key Offering: Cisplatin API, Platinum-Based Catalyst Intermediates

Johnson Matthey is a global leader in sustainable technologies and specialty chemicals, including pharmaceutical APIs. The company’s expertise in platinum group metals makes it a significant supplier of cisplatin API, with capabilities to ensure consistent quality and supply chain reliability for critical cancer therapeutics.

Strategic Initiatives:

• Advanced catalysis research for efficient API synthesis

• Sustainable manufacturing practices for platinum-based APIs

• Global supply chain infrastructure for regulated markets

Download FREE Sample Report:
Cisplatin API Market – View in Detailed Research Report

---

6️⃣ 5. Teva Pharmaceutical Industries Ltd. (Tapi Teva)

Headquarters: Petah Tikva, Israel
Key Offering: Cisplatin API through Tapi division

Teva, through its Tapi division, is a leading global supplier of generic APIs, including cisplatin. With extensive manufacturing experience and a robust global distribution network, Tapi Teva supplies high-quality cisplatin API to pharmaceutical companies worldwide, supporting affordable access to essential cancer medicines.

Strategic Initiatives:

• Scale advantages as one of the world’s largest generic API suppliers

• Strong regulatory expertise across North America, Europe, and emerging markets

• Investment in continuous manufacturing process improvements

---

5️⃣ 6. Acebright Pharmaceuticals (Guangzhou) Co., Ltd.

Headquarters: Guangzhou, Guangdong, China
Key Offering: Cisplatin API, Oncology-focused APIs

Acebright Pharmaceuticals specializes in the research, development, and manufacturing of anti-tumor APIs, with cisplatin being a key product in their portfolio. The company has established itself as a reliable supplier of high-purity cisplatin API to both domestic Chinese pharmaceutical companies and international partners.

Strategic Initiatives:

• Specialization in oncology APIs with dedicated manufacturing facilities

• Active pursuit of international regulatory certifications

• Research into improved synthesis routes for platinum-based drugs

---

4️⃣ 7. Vinkem Labs

Headquarters: Hyderabad, Telangana, India
Key Offering: Cisplatin API, Specialty Pharmaceutical Intermediates

Vinkem Labs is an emerging player in the API manufacturing space with a focus on complex molecules, including cisplatin. The Indian company leverages cost-effective manufacturing capabilities while maintaining international quality standards, positioning itself as a competitive supplier in the global cisplatin API market.

Strategic Initiatives:

• Strategic focus on niche and complex API manufacturing

• Cost-competitive production leveraging Indian manufacturing advantages

• Expanding regulatory footprint in regulated markets

---

3️⃣ 8. ChemGenix

Headquarters: Maharashtra, India
Key Offering: Cisplatin API, Custom Synthesis Services

ChemGenix specializes in the manufacturing of oncology APIs and intermediates, with cisplatin being a significant product in their portfolio. The company focuses on maintaining high purity standards and consistent quality, serving both formulation manufacturers and clinical research organizations globally.

Strategic Initiatives:

• Dedicated oncology API manufacturing expertise

• Flexible manufacturing capabilities for custom requirements

• Strong technical support for formulation development partners

---

2️⃣ 9. Hangzhou Haoke Bio-Tech Co., Ltd.

Headquarters: Hangzhou, Zhejiang, China
Key Offering: Cisplatin API, Biochemical Reagents

Hangzhou Haoke Bio-Tech is a biotechnology company engaged in the research, production, and sale of pharmaceutical intermediates and APIs, including cisplatin. The company serves the growing Chinese pharmaceutical market while expanding its international presence through quality-focused API manufacturing.

Strategic Initiatives:

• Integration of biotechnology approaches in traditional API manufacturing

• Focus on the rapidly growing domestic Chinese pharmaceutical market

• Investment in R&D for process optimization and impurity profiling

---

1️⃣ 10. Kunming Guiyan Pharmaceutical Co., Ltd.

Headquarters: Kunming, Yunnan, China
Key Offering: Cisplatin API, Natural Product-based Pharmaceuticals

Kunming Guiyan Pharmaceutical combines traditional medicinal expertise with modern pharmaceutical manufacturing capabilities. The company produces cisplatin API alongside its portfolio of natural product-based medicines, leveraging Yunnan’s strategic position in China’s pharmaceutical industry.

Strategic Initiatives:

• Strategic location in Yunnan, a hub for pharmaceutical manufacturing in China

• Diversified product portfolio including both synthetic and natural APIs

• Focus on serving the substantial domestic market while exploring exports

Get Full Report Here:
Cisplatin API Market – View in Detailed Research Report

---

🔬 Outlook: The Future of Cisplatin API Is Precision and Accessibility

The cisplatin API market is undergoing significant transformation. While cisplatin remains a cornerstone of chemotherapy regimens for various cancers, the industry is focusing on improved purity standards, cost-effective manufacturing, and supply chain resilience to meet global healthcare needs.

📈 Key Trends Shaping the Market:

• Increasing regulatory stringency for impurity profiling and control

• Growing demand from generic drug manufacturers as patents expire

• Shift of API manufacturing to Asia-Pacific regions for cost competitiveness

• Research into novel delivery systems and combination therapies using cisplatin

Get Full Report Here:
Cisplatin API Market – View in Detailed Research Report

The companies listed above are not only supplying a critical oncology therapeutic—they’re enabling global access to life-saving cancer treatments through reliable, high-quality API manufacturing.